Litcius/Paper detail

Non–Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement

Bashir Alaour, Enrico Ferrari, Dik Heg, David Tueller, Thomas Pilgrim, Olivier Müller, Stéphane Noble, Raban Jeger, Oliver Reuthebuch, Stefan Toggweiler, Christian Templin, Peter Wenaweser, Fabian Nietlispach, Maurizio Taramasso, Christoph Huber, Marco Roffi, Stephan Windecker, Stefan Stortecky

2024JACC: Cardiovascular Interventions11 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVitamin K antagonistValve replacementInternal medicineStroke (engine)Clinical endpointMyocardial infarctionAnticoagulantSurgeryCardiologyWarfarinAtrial fibrillationRandomized controlled trialStenosisEngineeringMechanical engineeringCardiac Valve Diseases and TreatmentsAtrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases
Non–Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement | Litcius